Benign breast lesions detected by positron emission tomography-computed tomography

Ana P. Benveniste; Wei Yang; Marcelo F. Benveniste; Osama R. Mawlawi; Edith M. Marom

doi:10.1016/j.ejrad.2014.02.010

Benign breast lesions detected by positron emission tomography-computed tomography

Ana P. Benveniste, Wei Yang, Marcelo F. Benveniste, Osama R. Mawlawi, Edith M. Marom

Imaging Physics

Research output: Contribution to journal › Review article › peer-review

13 Scopus citations

Abstract

¹⁸F-fluorodeoxyglucose positron emission computed tomography (FDG PET-CT) is widely used in the initial staging and response evaluation of patients with malignancy. This review describes a spectrum of benign breast findings incidentally detected by FDG PET-CT at staging that may be misinterpreted as malignancy. We describe the pattern of distribution and intensity of FDG uptake in a spectrum of benign breast diseases with their corresponding typical morphological imaging characteristics to help the nuclear medicine physician and/or general radiologist identify benign lesions, avoiding unnecessary breast imaging work-up and biopsies.

Original language	English (US)
Pages (from-to)	919-929
Number of pages	11
Journal	European Journal of Radiology
Volume	83
Issue number	6
DOIs	https://doi.org/10.1016/j.ejrad.2014.02.010
State	Published - Jun 2014

Keywords

Benign
Breast
FDG PET-CT

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.ejrad.2014.02.010

Cite this

@article{2f856251afb240e8ba8532f7dacc0f19,

title = "Benign breast lesions detected by positron emission tomography-computed tomography",

abstract = "18F-fluorodeoxyglucose positron emission computed tomography (FDG PET-CT) is widely used in the initial staging and response evaluation of patients with malignancy. This review describes a spectrum of benign breast findings incidentally detected by FDG PET-CT at staging that may be misinterpreted as malignancy. We describe the pattern of distribution and intensity of FDG uptake in a spectrum of benign breast diseases with their corresponding typical morphological imaging characteristics to help the nuclear medicine physician and/or general radiologist identify benign lesions, avoiding unnecessary breast imaging work-up and biopsies.",

keywords = "Benign, Breast, FDG PET-CT",

author = "Benveniste, {Ana P.} and Wei Yang and Benveniste, {Marcelo F.} and Mawlawi, {Osama R.} and Marom, {Edith M.}",

note = "Funding Information: Publication is approved by all authors and explicitly by the responsible authorities where the work was carried out (MD Anderson Cancer Center). The University of Texas MD Anderson Cancer Center is supported in part by a Cancer Center Support Grant ( CA016672 ) from the National Institutes of Health .",

year = "2014",

month = jun,

doi = "10.1016/j.ejrad.2014.02.010",

language = "English (US)",

volume = "83",

pages = "919--929",

journal = "European Journal of Radiology",

issn = "0720-048X",

publisher = "Elsevier Ireland Ltd",

number = "6",

}

TY - JOUR

T1 - Benign breast lesions detected by positron emission tomography-computed tomography

AU - Benveniste, Ana P.

AU - Yang, Wei

AU - Benveniste, Marcelo F.

AU - Mawlawi, Osama R.

AU - Marom, Edith M.

N1 - Funding Information: Publication is approved by all authors and explicitly by the responsible authorities where the work was carried out (MD Anderson Cancer Center). The University of Texas MD Anderson Cancer Center is supported in part by a Cancer Center Support Grant ( CA016672 ) from the National Institutes of Health .

PY - 2014/6

Y1 - 2014/6

N2 - 18F-fluorodeoxyglucose positron emission computed tomography (FDG PET-CT) is widely used in the initial staging and response evaluation of patients with malignancy. This review describes a spectrum of benign breast findings incidentally detected by FDG PET-CT at staging that may be misinterpreted as malignancy. We describe the pattern of distribution and intensity of FDG uptake in a spectrum of benign breast diseases with their corresponding typical morphological imaging characteristics to help the nuclear medicine physician and/or general radiologist identify benign lesions, avoiding unnecessary breast imaging work-up and biopsies.

AB - 18F-fluorodeoxyglucose positron emission computed tomography (FDG PET-CT) is widely used in the initial staging and response evaluation of patients with malignancy. This review describes a spectrum of benign breast findings incidentally detected by FDG PET-CT at staging that may be misinterpreted as malignancy. We describe the pattern of distribution and intensity of FDG uptake in a spectrum of benign breast diseases with their corresponding typical morphological imaging characteristics to help the nuclear medicine physician and/or general radiologist identify benign lesions, avoiding unnecessary breast imaging work-up and biopsies.

KW - Benign

KW - Breast

KW - FDG PET-CT

UR - http://www.scopus.com/inward/record.url?scp=84899992017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899992017&partnerID=8YFLogxK

U2 - 10.1016/j.ejrad.2014.02.010

DO - 10.1016/j.ejrad.2014.02.010

M3 - Review article

C2 - 24657106

AN - SCOPUS:84899992017

SN - 0720-048X

VL - 83

SP - 919

EP - 929

JO - European Journal of Radiology

JF - European Journal of Radiology

IS - 6

ER -

Benign breast lesions detected by positron emission tomography-computed tomography

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this